G01N 2333/33
From clostridium
Official title: from Clostridium (G)
G01N2333/33 (From clostridium) appears on 238 US grants and 369 published applications in this corpus.
Search patents in G01N- Granted patents
- 238
- Published applications
- 369
- Assignees
- 160
- Inventors
- 528
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 0 | 0 |
| 2002 | 3 | 0 |
| 2003 | 2 | 9 |
| 2004 | 1 | 8 |
| 2005 | 2 | 6 |
| 2006 | 3 | 7 |
| 2007 | 3 | 13 |
| 2008 | 6 | 18 |
| 2009 | 9 | 8 |
| 2010 | 6 | 19 |
| 2011 | 12 | 10 |
| 2012 | 8 | 15 |
| 2013 | 8 | 18 |
| 2014 | 9 | 21 |
| 2015 | 17 | 26 |
| 2016 | 22 | 24 |
| 2017 | 18 | 24 |
| 2018 | 15 | 14 |
| 2019 | 12 | 15 |
| 2020 | 13 | 21 |
| 2021 | 16 | 21 |
| 2022 | 13 | 18 |
| 2023 | 6 | 12 |
| 2024 | 10 | 17 |
| 2025 | 14 | 16 |
| 2026 | 2 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for the detection of Clostridium neurotoxins using a chimeric substrate fusion protein22 Sep 2026US 12,742,784 B2Prime Bio, Inc.
- Device, procedure and system for detecting bacterial pathogens including methicillin-resistant Staphylococcus aureus or clostridium difficile26 May 2026US 12,638,414 B2
- Cellular vamp cleavage assay9 Dec 2025US 12,493,035 B2Ipsen Biopharm Ltd.
- Methods for identifying anti clostridial neurotoxin compounds9 Dec 2025US 12,493,036 B2State of Israel, Israel Institute for Biological Research
- Antibodies for botulinum neurotoxins21 Oct 2025US 12,448,463 B2The Regents of the University of California
- Method for neurological sialadenosis modeling and drug efficacy testing through co-culture of human salivary gland organoids and neurocytomas13 Aug 2026US 2026/0234555 A1
- Cells sensitive to botulinum toxin into which specific gene has been inserted by lentivirus13 Aug 2026US 2026/0234692 A1Atgc Inc.
- Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon9 Jul 2026US 2026/0193688 A1Native Microbials, Inc.
- SNAP-25 Antibodies and Methods of Using the Same25 Jun 2026US 2026/0176334 A1Galderma Holding SA
- Intestinal biomarkers for gut health in domesticated birds28 May 2026US 2026/0146298 A1International N&H Denmark Aps
Most cited
By later US patents
- High affinity human antibodies to PCSK9143US 8,062,640 B2Regeneron Pharmaceuticals, Inc. · 2011
- Composition for inducing proliferation or accumulation of regulatory T cells98US 9,808,519 B2The University of Tokyo · 2017
- Composition for inducing proliferation or accumulation of regulatory T cells85US 9,662,381 B2The University of Tokyo · 2017
- Methods for concentrating ligands using magnetic particles80US 6,348,318 B1Biosite Diagnostics, Inc. · 2002
- High affinity human antibodies to PCSK975US 8,501,184 B2Regeneron Pharmaceuticals, Inc. · 2013